Supporting wider participation in science and Oxford
The Department of Oncology regularly provides science content for programmes aimed at encouraging young people to aspire to study science and widening participation in tertiary and Oxbridge education.  Across the UK young people regularly rule themselves out of science, out of tertiary education...
Professor Gillies McKenna receives 2018 Breur Award
Congratulations to Professor Gillies McKenna, Director of the CRUK/MRC Oxford Institute for Radiation Oncology, who is the recipient of the prestigious Breur Award for 2018. The award is named after Professor Klaas Breur, one of the founding fathers of ESTRO. As a tribute to Professor Breur’s...
Widening access to Oxford
Blog posted by: Martin Christlieb Applying to Oxford is a daunting prospect.  For many students in their last year of school, the idea of going to Oxford seems so far out of reach that it’s not worth applying.  For others, Oxford seems like a place where they couldn’t fit in or make a success of...
Dr Xiao Wan awarded NC3Rs fellowship
Congratulations to Dr Xiao Wan from Professor Eric O’Neill’s group for her success in obtaining an NC3Rs Training Fellowship for ‘Developing human organotypic perfused bioreactors for physiologically reproducible therapeutic compound screening of a tumour microenvironment’.  Xiao’s research at the...
Grant success for pancreatic cancer research
Congratulations to Dr Bart Cornelissen of the CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology who has secured a £200k grant from UK medical research charity, Pancreatic Cancer Research Fund (PCRF). Dr Cornelissen’s project aims to detect pancreatic tumours earlier and...
STEM for Britain silver medal success for James Larkin
Dr James Larkin, a postdoctoral researcher from Nicola Sibson’s lab in the CRUK/MRC Oxford Institute for Radiation Biology, has won a silver medal in 2018 STEM for Britain, a Parliamentary poster competition that gives researchers the chance to present their work to policymakers and politicians and...
Taking part – a researchers view of the Big Bang Fair
Blog posted by: Alexandr Khrapichev I really like to participate in outreach programmes.   It is a unique chance to master a short explanation of a complex scientific idea and present it to the public and a useful skill for both social and professional occasions. On a sunny Friday in March I went...
Cancer vaccine firm Oxford Vacmedix closes $12.5m Series A funding
South Korean and Chinese investors join round into Oxford University spinout developing cancer vaccines. Oxford Vacmedix UK Limited (OVM), a UK-based biopharma company focused on the development of cancer vaccines, has completed its Series A financing round of $12.5m (£9m) with a consortium of...
Days by the sea – a weekend of chocolate and radiotherapy
Blog posted by: Martin Christlieb Starting a conversation with strangers can be difficult at the best of times.  Starting a conversation on the subject of cancer and radiotherapy is even more so.  Engaging people on such subjects means catching their imagination, and fast. Setting a puzzle is an...
Medical Research Council grant success for Peter McHugh
Associate Professor Peter McHugh of the Department of Oncology has been awarded a 4 year grant from the Medical Research Council. The news comes hot on the heels of Professor McHugh's Cancer Research UK programme award. Grant success is tough, so this is a truly impressive achievement. The MRC...
Peter McHugh awarded CRUK grant to investigate how cancer cells resist treatment
The 5-year programme award will support research on the DNA repair mechanisms that protect cancer cells from therapy, informing the development of future therapies. Cancer therapies such as chemotherapy and radiotherapy aim to kill cancer cells by causing damage to their DNA. However, cancer cells...
Cancer en francais?
Blog posted by: Martin Christlieb On 25 January, I met a group of people whose lives have been touched by cancer.  Patients and their relatives whose world had been turned upside down by a disease that will affect nearly half of us. Cancer is terrible.  It threatens our lives and the resulting...
Successful CRUK research bursary for Oncology Clinical Fellow
Many congratulations to Robert Watson, a NIHR Academic Clinical Fellow in the laboratory of Benjamin Fairfax in the Department of Oncology. Robert was successful in his application for a CRUK pre-doctoral research bursary. Pre-doctoral research bursaries are awarded biannually by Cancer Research...
European Research Council success for Francesca Buffa
Congratulations to Associate Professor Francesca Buffa who has been awarded a five-year €2M grant by the European Research Council (ERC) to develop computer simulations of cancer cell behaviour, to help us personalise cancer treatment and prevent drug resistance. In many cases we know which parts...
Cancer communications and causing traffic jams
Blog posted by: Martin Christlieb Francesca Buffa has been awarded a five-year grant by the European Research Council (ERC) to develop computer simulations to personalise cancer treatment and prevent drug resistance. We increasingly understand which parts of a cell have gone wrong and make it...
Royal College of Radiologists accolade for Eric O'Neill
Regional Breast Cancer Academic Day marks NHS retirement for Professor Adrian Harris
A long and fateful journey
Curiosity led to the Carnival
Wriggling worms and migrating cancer
Oxford University scientist developing new treatments to tackle breast cancer that has spread to the brain
Worm study reveals role of stem cells in cancer
Congratulations to our new Professor and Associate Professor
New anti-cancer drug
Congratulations to student prize winners
Oxford science goes to Durham
Pedals Power Cancer Research
Oxford Professor receives Honorary Degree from the Institute of Cancer Research
A UNIQ course - Oncology welcomes tomorrow's scientists
Oxford collaborative science opens the way for a new drug for bowel cancer patients across the UK
About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.